In Indiana, Bill Advances to Support Cancer Patients in Clinical Trials

INDIANAPOLIS, Ind. — A bill aimed at easing the financial burden for cancer patients participating in clinical trials was advanced by a unanimous vote out of the public health committee of the Indiana House of Representatives.

The bill, sponsored by Democratic State Rep. Robin Shackleford, would create the Cancer Clinical Trial Participation Program, allowing independent third parties, such as patient groups, corporations or government entities, to cover ancillary costs for patients taking part in clinical trials in Indiana.

“Every year, millions of Hoosiers face a cancer diagnosis. As a state, we need to ensure that financial barriers do not prevent individuals from participating in lifesaving clinical trials,” Shackleford said in a written statement.

“By providing support to help cover costs like travel, lodging and other out-of-pocket expenses, we can help Hoosiers access the treatments that could save their lives,” she said, adding that she sees the legislation as “a critical part of ensuring that no one is left behind due to financial challenges when it comes to fighting cancer.”

Cancer is the second leading cause of death in Indiana, with an estimated 2.4 million of its residents, or approximately two in five people, eventually facing a diagnosis. 

Despite the importance of clinical trials in discovering new treatments, less than 7% of eligible patients currently participate. Barriers to participation include the cost of travel, lodging and missed work, which can be a significant burden on patients and their families.

“Cancer is not a partisan issue,” Shackleford said. “This bill serves as an example of how we can build bipartisan support to address the needs of our communities. 

“By working together across party lines, we can improve the health and well-being of all Hoosiers, regardless of their background or financial situation,” she said.

Dan can be reached at [email protected] and @DanMcCue